TABLE OF CONTENTS
|  | | | | Volume 31, Issue 9 (September 2017) |  | In this issue
 Perspective
Reviews
Concise Review
Original Articles
Letters to the Editor
Correspondence
Also new
   AOP
| | | | | | Advertisement | | | | | | Perspective | Top | | New drugs in myeloma: beware of phase I trial results, beware of cost and demand for new trials P Moreau Leukemia 2017 31: 1843-1844; advance online publication, June 30, 2017; 10.1038/leu.2017.188 Full Text | | Reviews | Top | | Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era L Falchi, H M Kantarjian and S Verstovsek Leukemia 2017 31: 1845-1854; advance online publication, May 22, 2017; 10.1038/leu.2017.150 Abstract | Full Text | | | | Gemtuzumab ozogamicin in acute myeloid leukemia C D Godwin, R P Gale and R B Walter Leukemia 2017 31: 1855-1868; advance online publication, June 13, 2017; 10.1038/leu.2017.187 Abstract | Full Text | | Concise Review | Top | | CHIP, ICUS, CCUS and other four-letter words R Bejar Leukemia 2017 31: 1869-1871; advance online publication, June 8, 2017; 10.1038/leu.2017.181 Abstract | Full Text | | Original Articles | Top | | CHRONIC LYMPHOCYTIC LEUKEMIA | Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199) V M Patel, K Balakrishnan, M Douglas, T Tibbitts, E Y Xu, J L Kutok, M Ayers, A Sarkar, R Guerrieri, W G Wierda, S O'Brien, N Jain, H M Stern and V Gandhi Leukemia 2017 31: 1872-1881; advance online publication, December 26, 2016; 10.1038/leu.2016.382 Abstract | Full Text | | | | Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22 F Arruga, B Gizdic, C Bologna, S Cignetto, R Buonincontri, S Serra, T Vaisitti, K Gizzi, N Vitale, G Garaffo, E Mereu, F Diop, F Neri, D Incarnato, M Coscia, J Allan, R Piva, S Oliviero, R R Furman, D Rossi, G Gaidano and S Deaglio Leukemia 2017 31: 1882-1893; advance online publication, December 26, 2016; 10.1038/leu.2016.383 Abstract | Full Text | | | | Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy G Cutrona, S Matis, M Colombo, C Massucco, G Baio, F Valdora, L Emionite, S Fabris, A G Recchia, M Gentile, C E Neumaier, D Reverberi, R Massara, S Boccardo, L Basso, S Salvi, F Rosa, M Cilli, S Zupo, M Truini, P Tassone, M Calabrese, M Negrini, A Neri, F Morabito, F Fais and M Ferrarini Leukemia 2017 31: 1894-1904; advance online publication, January 5, 2017; 10.1038/leu.2016.394 Abstract | Full Text | | | | PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions Y-J Li, L Sun, Y Shi, G Wang, X Wang, S E Dunn, C Iorio, R A Screaton and D E Spaner Leukemia 2017 31: 1905-1914; advance online publication, January 4, 2017; 10.1038/leu.2016.395 Abstract | Full Text | | | | Trends in overall survival and costs of multiple myeloma, 2000–2014 OPEN R Fonseca, S Abouzaid, M Bonafede, Q Cai, K Parikh, L Cosler and P Richardson Leukemia 2017 31: 1915-1921; advance online publication, December 23, 2016; 10.1038/leu.2016.380 Abstract | Full Text | | | | Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial L Rosiñol, A Oriol, A I Teruel, A L de la Guía, MaJ Blanchard, J de la Rubia, M Granell, MaA Sampol, L Palomera, Y González, MaA Etxebeste, R Martínez-Martínez, M T Hernández, F de Arriba, A Alegre, MaT Cibeira, MaV Mateos, J Martínez-López, J J Lahuerta, J San Miguel and J Bladé on behalf of the Programa Español de Tratamientos en Hematología/Grupo Español de Mieloma (PETHEMA/GEM) Leukemia 2017 31: 1922-1927; advance online publication, January 23, 2017; 10.1038/leu.2017.35 Abstract | Full Text | | | | MYELODYSPLASTIC SYNDROME | The clonal origins of leukemic progression of myelodysplasia T Kim, M S Tyndel, H J Kim, J-S Ahn, S H Choi, H J Park, Y-k Kim, D-H Yang, J-J Lee, S-H Jung, S Y Kim, Y H Min, J-W Cheong, S K Sohn, J H Moon, M Choi, M Lee, Z Zhang and D(D H) Kim Leukemia 2017 31: 1928-1935; advance online publication, January 16, 2017; 10.1038/leu.2017.17 Abstract | Full Text | | | | Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms J Rinke, J P Müller, M F Blaess, A Chase, M Meggendorfer, V Schäfer, N Winkelmann, C Haferlach, N C P Cross, A Hochhaus and T Ernst Leukemia 2017 31: 1936-1943; advance online publication, June 19, 2017; 10.1038/leu.2017.190 Abstract | Full Text | | | | A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes OPEN U Platzbecker, A Symeonidis, E N Oliva, J S Goede, M Delforge, J Mayer, B Slama, S Badre, E Gasal, B Mehta and J Franklin Leukemia 2017 31: 1944-1950; advance online publication, June 19, 2017; 10.1038/leu.2017.192 Abstract | Full Text | | | | CHRONIC MYELOPROLIFERATIVE NEOPLASMS | Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells D T Saenz, W Fiskus, Y Qian, T Manshouri, K Rajapakshe, K Raina, K G Coleman, A P Crew, A Shen, C P Mill, B Sun, P Qiu, T M Kadia, N Pemmaraju, C DiNardo, M-S Kim, A J Nowak, C Coarfa, C M Crews, S Verstovsek and K N Bhalla Leukemia 2017 31: 1951-1961; advance online publication, February 2, 2017; 10.1038/leu.2016.393 Abstract | Full Text | | | | TRANSCRIPTIONAL CONTROL AND SIGNAL TRANSDUCTION, CELL CYCLE | Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia D A C Fisher, O Malkova, E K Engle, C A Miner, M C Fulbright, G K Behbehani, T B Collins, S Bandyopadhyay, A Zhou, G P Nolan and S T Oh Leukemia 2017 31: 1962-1974; advance online publication, December 23, 2016; 10.1038/leu.2016.377 Abstract | Full Text | | | | PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias C Ronchini, A Brozzi, L Riva, L Luzi, A M Gruszka, G E M Melloni, E Scanziani, G Dharmalingam, M Mutarelli, V Belcastro, S Lavorgna, V Rossi, O Spinelli, A Biondi, A Rambaldi, F Lo-Coco, D di Bernardo and P G Pelicci Leukemia 2017 31: 1975-1986; advance online publication, December 27, 2016; 10.1038/leu.2016.386 Abstract | Full Text | | Letters to the Editor | Top | | Spotlight on pomalidomide: could less be more? OPEN T Zander, S Aebi, T Pabst, C Renner and C Driessen Leukemia 2017 31: 1987-1989; advance online publication, May 22, 2017; 10.1038/leu.2017.156 Full Text | | | | Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia A M Heilmann, A B Schrock, J He, M Nahas, K Curran, N Shukla, S Cramer, L Draper, A Verma, R Erlich, J Ross, P Stephens, V A Miller, S M Ali, J-A Verglio, M S Tallman and T I Mughal Leukemia 2017 31: 1989-1992; advance online publication, May 29, 2017; 10.1038/leu.2017.161 Full Text | | | | Identification of a novel PML-RARG fusion in acute promyelocytic leukemia J-S Ha, Y R Do, C-S Ki, C Lee, D-H Kim, W Lee, N-H Ryoo and D-S Jeon Leukemia 2017 31: 1992-1995; advance online publication, May 30, 2017; 10.1038/leu.2017.167 Full Text | | | | MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations A Stengel, W Kern, M Meggendorfer, T Haferlach and C Haferlach Leukemia 2017 31: 1995-1997; advance online publication, June 8, 2017; 10.1038/leu.2017.180 Full Text | | | | Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014 A D'Souza, M-J Zhang, J Huang, M Fei, M Pasquini, M Hamadani and P Hari Leukemia 2017 31: 1998-2000; advance online publication, June 13, 2017; 10.1038/leu.2017.185 Full Text | | | | The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia OPEN A Rio-Machin, G Gómez-López, J Muñoz, F Garcia-Martinez, A Maiques-Diaz, S Alvarez, R N Salgado, M Shrestha, R Torres-Ruiz, C Haferlach, M J Larráyoz, M J Calasanz, J Fitzgibbon and J C Cigudosa Leukemia 2017 31: 2000-2005; advance online publication, June 20, 2017; 10.1038/leu.2017.194 Full Text | | | | Recurrent cyclin D2 mutations in myeloid neoplasms V Khanna, C A Eide, C E Tognon, J E Maxson, B Wilmot, D Bottomly, S McWeeney, D K Edwards V, B J Druker and J W Tyner Leukemia 2017 31: 2005-2008; advance online publication, June 20, 2017; 10.1038/leu.2017.195 Full Text | | Correspondence | Top | | Do we need to distinguish exosomes from microvesicles in hematological malignancies? A Caivano, L Del Vecchio and P Musto Leukemia 2017 31: 2009-2010; advance online publication, June 28, 2017; 10.1038/leu.2017.205 Full Text | | | | |  | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | | | |
No comments:
Post a Comment